MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10.

导出 OA

翻译打印收藏纠错

作者： Jiayu,Wu ^[1] ; Qianyin,Huang ^[1] ; Peilin,Li ^[1] ; Yuxian,Wang ^[2] ; Chenghao,Zheng ^[3] ; Xianghong,Lei ^[1] ; Shuting,Li ^[1] ; Wangqiu,Gong ^[1] ; Bohui,Yin ^[1] ; Congwei,Luo ^[1] ; Jing,Xiao ^[1] ; Weidong,Zhou ^[1] ; Zhaozhong,Xu ^[4] ; Yihua,Chen ^[5] ; Fenfen,Peng ^[6] ; Haibo,Long ^[7]

作者单位： Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. ^[1] Department of Gerontology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. ^[2] Second Clinical Medical School, Southern Medical University, Guangzhou 510280, China. ^[3] Department of Emergency, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. ^[4] Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China 13724005373@163.com. ^[5] Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China doctorpff@163.com. ^[6] Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China longhb1966@163.com. ^[7]

关键词 epithelial-mesenchymal transition (EMT)fibroblast growth factor 10 (FGF10)fibrosis kidney disease mRNA microRNA (miRNA)peritoneal dialysis (PD)renal replacement therapy translation regulation